Emily Boes, DO
Dermatology · Cedar Rapids, IANPI 1417307497
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $362 of the $503 with a category attached, or 72.0%. It is spread thinly across 12 manufacturers, the largest accounting for just 18.9%. Reporting peaked in 2023 at $191 and has fallen 57.2% since, to $82 in 2025. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.
Across 23 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$95
- AbbVie$88
- Novartis$61
- Regeneron Healthcare Solutions, Inc.$55
- Pfizer$46
- UCB, Inc.$43
- plus $116 from 6 others
What the payments were for
- Food & beverage$36272%
- Education$14128%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $95 |
| AbbVie | 4 | $88 |
| Novartis | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Pfizer | 3 | $46 |
| UCB, Inc. | 2 | $43 |
| Organon | 2 | $25 |
| Bristol Myers Squibb | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$503 in reported general payments places this provider in the 40th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $1,972 |
| Fluorouracil | 16 | $1,170 |
| Metronidazole | 13 | $900 |
| Ketoconazole | 38 | $608 |
| Fluocinonide | 13 | $491 |
| Betamethasone Dipropionate | 13 | $478 |
| Doxycycline Monohydrate | 17 | $455 |
| Mupirocin | 52 | $379 |
| Triamcinolone Acetonide | 47 | $349 |
| Minoxidil | 20 | $228 |
| Hydrocortisone | 42 | $187 |
| Prednisone | 16 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cedar Rapids
- David KnutsonCedar Rapids$60K
- John WollnerCedar Rapids$2K
- Lauren DoughtymcdonaldCedar Rapids$1K
- Stacy KirbyCedar Rapids$863
- Mark ClevelandCedar Rapids$500
- Matthew LandherrCedar Rapids$413
- Roger CeilleyWest Des Moines$82K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.